← Back to Search

Behavioural Intervention

Latino caregivers and the Latino older adults with cancer (OACs) for Caregiver

N/A
Recruiting
Led By Kelly McConnell, PhD
Research Sponsored by Memorial Sloan Kettering Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

Study Summary

"This trial aims to determine if an anxiety treatment program is both feasible and helpful for Latino older adults with cancer and their caregivers."

Who is the study for?
This trial is for Latino older adults with cancer and their caregivers. It aims to see if an anxiety treatment program can help them.Check my eligibility
What is being tested?
The intervention being studied is the Managing Anxiety from Cancer (MAC) program, designed to reduce anxiety in Latino older adults with cancer and their caregivers.See study design
What are the potential side effects?
Since this trial involves a non-medical intervention focused on managing anxiety, there are no direct medical side effects expected.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
percentage of participants to complete all study procedures

Trial Design

1Treatment groups
Experimental Treatment
Group I: Latino caregivers and the Latino older adults with cancer (OACs)Experimental Treatment1 Intervention
The intervention, MAC, is a seven-session (45- 60 minutes per session) psychotherapy intervention delivered via videoconference and/or telephone by licensed social workers. All sessions will be audio-recorded. MAC content, structure, and length are consistent with core components of cognitive behavioral therapy (CBT) (Freeman, 2004).

Find a Location

Who is running the clinical trial?

Memorial Sloan Kettering Cancer CenterLead Sponsor
1,937 Previous Clinical Trials
588,260 Total Patients Enrolled
Kelly McConnell, PhDPrincipal InvestigatorMemorial Sloan Kettering Cancer Center
2 Previous Clinical Trials
178 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the recruitment phase still ongoing for potential participants in this clinical trial?

"As per clinicaltrials.gov, this ongoing trial is actively pursuing eligible participants. The original post was made on March 5th, 2024 and the latest update occurred on the same day."

Answered by AI

At how many distinct sites is this clinical trial being conducted?

"The current recruitment phase of this study involves enrolling participants at 7 distinct sites, with locations in Middletown, Commack, Harrison, and 7 other cities. Opting for the nearest site can help reduce travel requirements upon enrollment."

Answered by AI

What is the current number of participants being recruited for this research project?

"Affirmative. Information from clinicaltrials.gov indicates that this research study is currently in the process of enrolling participants. The trial was initially posted on March 5, 2024, and recently revised on the same date. It aims to recruit a total of 60 subjects across seven different sites."

Answered by AI
~40 spots leftby Mar 2026